Synergistic effects of fumonisin B1 and ochratoxin A: Are in vitro cytotoxicity data predictive of in vivo acute toxicity?

Toxicology

Volumn 201, Issue 1-3, 2004, Pages 115-123

  Creppy, Edmond E ^a   Chiarappa, Patrizia ^b   Baudrimont, Isabelle ^a   Borracci, Pietro ^b   Moukha, Serge ^a,c   Carratù, Maria R ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b POLICLINICO   (Italy)

^c CEMAGREF   (France)

Author keywords

C6 glioma cells; Caco 2 cells; Fumonisin B1; Neutral red uptake test; Ochratoxin A; Vero cells

Indexed keywords

AFLATOXIN; FUMONISIN B1; MYCOTOXIN; OCHRATOXIN; TRICHOTHECENE DERIVATIVE; ZEARALENONE;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CHRONIC TOXICITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; FOOD CONTAMINATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MOULD; NEUROTOXICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; TOXICOKINETICS; TREMOR;

ANIMALS; CACO-2 CELLS; CARCINOGENS; CERCOPITHECUS AETHIOPS; DRUG SYNERGISM; FUMONISINS; HUMANS; MYCOTOXINS; NEUTRAL RED; OCHRATOXINS; PREDICTIVE VALUE OF TESTS; TUMOR CELLS, CULTURED; VERO CELLS;

ANIMALIA;

EID: 3543069308     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.04.008     Document Type: Article

References (60)

1. Abado-Becognee K., Mobio T.K., Ennamany R., Fleurat-Lessard F., Shier W.T., Badria F., Creppy E.E. Cytotoxicity of fumonisin B1: implication of lipid peroxidation and inhibition of protein and DNA syntheses. Arch. Toxicol. 72:1998;233-236
2. Abel S., Gelderblom W.C.A. Oxidative damage and fumonisin B1-induced toxicity in primary rat hepatocytes and rat liver in vivo. Toxicology. 131:1998;120-131
3. Arora R.G., Frolen H. Interference of mycotoxins with prenatal development of the mouse. Part II. Ochratoxin A induced teratogenic effects in relation to the dose and stage of gestation. Acta Vet. Scand. 22:1981;535-552
4. Balls, M., Riddell, R.J., Horner, S.A., Clothier, R.H., 1987. The FRAME approach to the development, validation, and evaluation of in vitro alternative methods. In: Goldberg A.M. (Ed.), In Vitro Methods in Toxicology - Approaches to Validation, Alternative Methods in Toxicology 5. Mary Ann Liebert, Inc., New York, USA, pp.45-58.
5. Baudrimont I., Betbeder A.-M., Gharbi A., Pfohl-Leszkowicz A., Dirheimer G., Creppy E.E. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of Ochratoxin A in rats. Toxicology. 89:1994;101-111
6. Baudrimont I., Ahouandjivo R., Creppy E.E. Prevention of lipid peroxidation induced by ochratoxin A in Vero cells in culture: effects of several preventing agents. Chem. Biol. Interact. 104:1997;29-40
7. Bennet J.W., Klich M. Mycotoxins. Clin. Microbial. Rev. 16:2003;497-516
8. Carlton, W.W., Tuite J., 1977. Metabolites of P. viridicatum toxicology. In: Rodricks, J.V., Hesseltine, C.W., Mehlman, M.A. (Eds.), Mycotoxins in Human an Animal Health. Pathtox, Park Forest South, IL, pp. 525-541.
9. Chu F.S. Interaction of ochratoxin A with bovine serum albumin. Arch. Biochem. Biophys. 147:1971;359-366
10. Creppy E.E., Lugnier A.A.J., Fasiolo F., Heller K., Röschenthaler R., Dirheimer G. In vitro inhibition of yeast phenylalanyl-tRNA synthetase by ochratoxin A. Chem. Biol. Interact. 24:1979;257-261
11. Creppy E.E., Schlegel M., Röschenthaler R., Dirheimer G. Phenyalanine prevents acute poisoning by ochratoxin A in mice. Toxico. Lett. 6:1980;77-80
12. Creppy, E.E., Lorkowski, G., Röschenthaler, R., Dirheimer, G., 1982. Kinetic of immunosuppressive action of ochratoxin A on mice. Mycotoxins and Phytotoxins, Technical University, Vienna, pp. 289-292.
13. Creppy E.E., Kern D., Steyn P.S., Vleggaar R., Röschenthaler R., Dirheimer G. Comparative study of the effect of ochratoxin A analogues on yeast aminoacyl-tRNA synthetase and on the growth and protein synthesis of hepatoma cells. Toxicol. Lett. 19:1983a;217-224
14. Creppy E.E., Stormer F.C., Röschenthaler R., Dirheimer G. Effects of two metabolites of ochratoxin A, [4R]-4-hydroxyochratoxin A and ochratoxin alpha, on the immune response in mice. Infect. Immunol. 39:1983b;1015-1018
15. Creppy E.E., Röschenthaler R., Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem. Toxicol. 22:1984;883-886
16. Creppy E.E., Kane A., Dirheimer G., Lafarge-Frayssinet C., Mousset S., Frayssinet C. Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen liver and kidney. Toxicol. Lett. 28:1985;29-35
17. Dawlatana M., Coker R.D., Nagler M.J., Wild C.P., Hassan M.S., Blunden G. The occurrence of mycotoxins in key commodities in Bengladesh: surveillance results from 1993 to 1995. J. Nat. Toxins. 11:2002;379-386
18. Diaz, C.T., Sogbe, E., Ascanio, E., Hernandez, M., 2001. Ochratoxin A and fumonisin B1 natural interaction in pigs. Clinical and pathological studies, Rev. Cient Fac. Cien. V., 314-321.
19. Galtier P., Bonen B., Charpenteau J.L., Bodin G., Alvinerie M., More J. Physiopatology of haemorrhagic syndrome related to ochratoxin A intoxication in rats. Food Cosmet. Toxicol. 17:1979;49-53
20. Gelderblom W.C.A., Jaskiewicz K., Marasas W.F.O., Thiel P.G., Horak R.M., Vleggaar R., Kriek N.P.J. Fumonisins novel mycotoxins with cancer-promoting activity produced by Fusarium miniliforme. Appl. Environ. Microbiol. 54:1988;1806-1811
21. Gupta M., Bandyopaddhyay S., Paul B., Majumder S.K. Hematological changes produced in mice by ochratoxin A. Toxicology. 14:1979;95-98
22. Halle, W., 1985. Grundlagen der Zytotoxizität in vitro und ihre Bedeutung für die toxikologische Prüfung von Antiseptika. In: Handbuk der Antiseptik, Vol. I, 5, Grundlangen der Antiseptik. Toxische und allergische Nebenwirhumgen von Antiseptika (Kramer, A., Berencsi, G., Weuffen, W., (Eds.)), Berlin, Germany: Volk und Gesundheit, pp. 84-112.
23. Halle, W., Goeres, E., 1988. Register der Zytotoxizität (IC50) in der Zellkultur und Möglichketen zur Abschätzung der akuten Toxizität (LD50). In: Beiträge zur Wirkstoffforschung (Oehme, P., Loewe, H., Goeres E. (Eds.)), Berlin, Germany: Institut für Wirkstoffforschung, pp. 108.
24. Halle W., Spielmann H. Two procedures for the prediction of acute toxicity (LD50) from cytotoxicity data. ATLA. 20:1992;40-49
25. Halle, W., Spielmann, H., 1997. Die Prädiktion der akuten Toxizität mit Hilfe von Zytotoxizitätsdaten. In: Forschung ohne Tiersuche 1966 (Schöffl, H., Spielmann, H., Tritthart, H.A., Cussler, K., Goeschel, A.F., Gruber, F.P., Reinhardt C.A. (Eds.)), pp. 10-19. Wien, Austria: Springer.
26. Halle, W., 1998. Toxizitätsprüfingen in Zellkulturen für eine Vorhersage der akuten Toxizität (LD50) zur Einsparung von Tierversuchen, Life Sciences/Lebens-wissenschaften. Vol. 1, pp. 94 Jülich: Forschungszentrum Jülich.
27. 1 a toxic metabolite of Fusarium moniliforme. J. Vet. Diagn. Invest. 2:1990;217-221
28. Haubeck H.D., Lorkowski G., Kolsch E., Röschenthaler R. Immunosuppression by ochratoxin A and its prevention by phenylalanine. Appl. Environ. Microbiol. 41:1981;1040-1042
29. Humpf H.U., Schmelz E.M., Filmore F.I., Vesper H., Vales T.R., Wang E., Menaldino D.S., Liotta D.C., Merrill A.H. Jr. Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. J. Biol. Chem. 273:1988;19060-19064
30. Javed T., Richard J.L., Bennet G.A., Dombrink-Kurtzman M.A., Bunte R.M., Koelkebeck K.W., Cote L.M., Leeper R.W., Buck W.B. Embryopathic and embryocidal effects of purified fumonisin B1 or Fusarium proliferatum culture material extract on chicken embryos. Mycopathologia. 123:1993;185-193
31. Kanisawa M., Suzuki S. Induction of renal and hepatic tumors in mice by ochratoxin A a mycotoxin. Gann. 69:1978;599-600
32. Krogh P., Axelsen N.H., Elling F., Gyard-Hansen N., Hald B., Hyldgaard-Jensen J., Larsen A.E., Madsen A., Mortensen H.P., Moller T., Peterson O.K., Ravnskov U., Rostgaard M., Aalund O. Experimental porcine nephropathy changes of renal functiun and structure induced by ochratoxin A-contaminated feed. Acta Path. Microbiol. Scand A. 246(suppl.):1974;21
33. Krogh P. Causal association of mycotoxic nephropathy. Acta Pathol. Microbiol. Scand. Suppl. 269:1978;1-28
34. Krogh, P., 1987. Ochratoxins in food. In: Krogh, P. (Ed.) Mycotoxin in food. New Yok Academic Press, New York, pp. 97-121.
35. Krogh P., Gyrd-Hansen N., Hald B., Larsen S., Nielsen J.P., Smith M., Ivanoff C., Meisner H. Renal enzyme activities in experimental ochratoxin A- induced porcin nephropathy: diagnostic potential of phospho-enol pyruvate carboxykinase and gamma-glutamyl transpeptidase actvity. J. Toxicol. Environ. Hlth. 23:1988;1-14
36. Krogh P. Role of ochratoxin A in disease causation. Food Chem. Toxicol. 30:1992;213-224
37. Kubena L.F., Edrington T.S., Harvey R.B., Phillips T.D., Sarr A.B., Rottinghaus G.E. Individual and combined effects of fumonisin B1 present in fusarium moniliforme culture material and diacetoxyscirpenol or ochratoxin A in turkey poults. Poult. Sci. 76:1997;256-264
38. Kuiper-Goodman T., Scott P.M. Risk assessment of mycotoxin ochratoxin A. Biomed. Environ. Sci. 2:1989;179-248
39. Lanza G.M., Washburn K.W., Wyatt R.D. Variation with age in response of broilers to aflatoxin. Poult. Sci. 59:1980;282-288
40. Manning R.O., Wyatt R.D. Toxicity of Aspergillus ochraceus contaminated wheat and different chemical forms of ochratoxin A in broiler chicks. Poult. Sci. 63:1984;458-465
41. Marasas W.F., Kellerman T.S., Gelderblom W.C., Coetzer J.A., Thiel P.G., van der Lugt J.J. Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J. Vet. Res. 55:1988;197-203
42. Mayura K., Parker R., Berndt W.O., Philipps T.D. Ochratoxin A-induced teratogenesis in rats: partial protection by phenylalanine. Appl. Environ. Microbiol. 48:1984;1186-1188
43. Mobio T.A., Abado-Begonee K., Ennamany R., Fleurat-Lessart F., Shier W.T., Badria F., Creppy E.E. Lipid peroxidation as a sensitive marker of cellular response to fumonisin B1: implication in cytotoxicity and inhibition of protein DNA syntheses. Toxicol. Lett. 88:1996;71
44. Mobio T.A., Abado-Begonee K., Ennamany R., Fleurat-Lessart F., Shier W.T., Badria F., Creppy E.E. Implication of lipid peroxidation in cytotoxicity and genotoxicity of fumonisin B1. Toxicol. Lett. 95:1998;154
45. 1: cell cycle arrest and DNA base modificaion in C6 glioma Cells. Toxicol. Appl. Pharmacol. 164:2000;91-96
46. 1 in rat C6 glioma cells and p53-null mouse embryo fibroblasts. Toxicology. 183:2003;65-75
47. Monnet-Tschudi F., Sorg O., Honegger P., Zurich M.G., Huggett A.C., Schilter B. Effects of the naturally occurring food mycotoxin ochratoxin A on brain cells in culture. Neurotoxicology. 18:1997;831-839
48. Muller G., Kielstein P., Rosner H., Berndt A., Heller M., Kohler H. Studies on the influence of combined administration of ochratoxin A, fumonisin B1 Deoxynivalenol and T2 toxin on immune and defence reactions in weaner pigs. Mycosis. 42:1999;485-493
49. NTP, 1989. Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A. (CAS No. 303-47-9) in F 344/N rats (gavage studies). In: Boorman, G. (Ed.), National Institute of Health Publication No. 89-2813, US Department of Health and Human Resources, Research Triangle Park, NC, USA.
50. Omar R.F., Hasinoff B.B., Mejilla F., Rahimtula A.D. Mechanism of ochratoxin A-stimulated lipid peroxidation. Biochem. Pharmacol. 40:1990;1183-1191
51. Omar R.F., Rahimtula A.D., Bartsch H. Role of cytochrome P450 in ochratoxin A-stimulated lipid peroxidation. J. Biochem. Toxicol. 6:1991;203-209
52. Petkova-Bocharova T., Chernozemsky I.N., Castegnaro M. Ochratoxin A in human blood in relation to Balkan endemic neuropathy and urinary system tumours in Bulgaria. Food Addit. Contam. 5:1988;299-301
53. Pfohl-Leszkowicz, A., Chakor, K., Creppy, E.E., Dirheimer, G., 1991. DNA-adduct formation in mice treated with ochratoxin A. In: Castagnaro, M., Plestina, R., Dirheimer, G., Chernozemsky I.N., Bartsch H. (Eds.), Mycotoxin, Endemic Nephropathy and Urinary Tract Tumors, IARC Scientific Publications No. 115, Lyon, pp. 245-253.
54. Pitout M.J. The effect of ochratoxin A on glycogen storage in rat liver. Toxicol. Appl. Pharmacol. 13:1968;299-306
55. Plestina R. Some features of Balkan endemic nephropathy. Food Chem. Toxicol. 30:1992;177-181
56. Rahimtula A.D., Bereziat J.C., Bussachini-Griot V., Bartsch H. Lipid peroxidation as possible cause of Ochratoxin A toxicity. Biochem. Pharmacol. 37:1988;4469-4477
57. Shephard G.S., Thiel P.G., Sydenham E.W., Alberts J.F., Cawood M.E. Distribution and excretion of a single dose mycotoxin fumonisin B1 in a non-human primate. Toxicon. 32:1993;735-741
58. Spielmann H., Genschow E., Liebsch M., Halle W. Determination of the starting dose for acute oral toxicity (LD50) testing in the up and down procedure (UDP) from cytotoxicity data. ATLA. 27:1999;957-966
59. Wang E., Ross F.P., Wilson T.M., Riley R.T., Merrill A.H. Jr. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J. Nutr. 122:1992;1706-1716
60. Wannemacher, R.W., Bunner, D.L., Neufeld, H.A., 1991. Toxicity of tricothecenes and other related mycotoxins in laboratory animals. In: Smith, J.E., Anderson, R.A. (Eds.), Mycotoxins and Animal Foods. CRC Press, Boca Raton, FL, pp. 499-552.